Drug application
THAM-E (POTASSIUM CHLORIDE, SODIUM CHLORIDE, TROMETHAMINE)
Drugs@FDA NDA 013025 · HOSPIRA
Key facts
| Drug name | THAM-E |
|---|---|
| Active ingredients | POTASSIUM CHLORIDE, SODIUM CHLORIDE, TROMETHAMINE |
| Application type | NDA |
| Application number | 013025 |
| Company | HOSPIRA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 370MG/VIAL;1.75GM/VIAL;36GM/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity and Type 4 - New Combination |
| Latest submission status date | Dec 16, 1965 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: